Van Vollenhoven R, Hahn BH, Tsokos GC, et al. Efficacy and Safety of Ustekinumab, an Interleukin 12/23 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: Results of a Phase 2, Randomized Placebo-Controlled Study. ACR 2017, abstract 6L.
Gunstige effecten van belimumab op nieruitkomsten bij patiënten met lupus nefritis
jan 2022 | Chronische nierschade, SLE